On September 12, 2023, an independent advisory committee to the United States’ Food and Drug Administration (the “FDA”) announced that its members unanimously agreed that phenylephrine, an ingredient commonly found in over-the-counter cold/flu and allergy medications, is ineffective as a nasal decongestant when taken in tablet form.
The FDA’s committee explained that phenylephrine, when consumed in tablet form, metabolizes rapidly in the gut once ingested, allowing only a fraction of the phenylephrine consumed to reach the consumer’s nose and provide the represented medicinal benefits.
Many companies in Canada sell phenylephrine in tablet form, including Shoppers Drug Mart, Wal-Mart Canada, RB Health, Procter & Gamble, GSK Canada, and Johnson & Johnson. Phenylephrine is found in the following oral medications used to treat cold/flu and allergy symptoms:
If you have purchased one or more products containing phenylephrine listed above, please reach out to us by filling in the form on this webpage.
Sep 27, 2023 – Vancouver Sun – Bought certain cold meds? You may get refund in proposed B.C. class action lawsuit
Sep 27, 2023 – Vancouver Is Awesome – B.C. lawsuit targets drugmakers, retailers for selling ineffective cold medicine
Sep 26, 2023 – Law360 Canada – Class-action lawsuits filed against medication manufacturers in B.C., Quebec